AskBio Announces 11 Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting in 2023
AskBio presentations cover pre-clinical research into immune responses to AAV, data on methods to improve the efficacy of AAV-gene therapy and research into improved analytics and bioassays.
- AskBio presentations cover pre-clinical research into immune responses to AAV, data on methods to improve the efficacy of AAV-gene therapy and research into improved analytics and bioassays.
- By targeting these therapy areas, AskBio aims to deliver breakthrough treatments that could benefit more than 35 million patients worldwide.1–7
AskBio's presentations at ASGCT include:
A Platform Approach for Adeno-Associated Virus Manufacturing to Support Gene Therapy Products. - Presented by Audry Fernandez, R&D, Asklepios BioPharmaceutical, Inc. [Oral presentation: 16:00 May 18 (Room 411)]
Impact of Genetic Diversity on Gene Therapy Efficacy. - Presented by Sandro Alves, Head preclinical (France), Asklepios BioPharmaceutical, Inc. [Poster presentation: 12:00 May 19 (Poster #1261)]